Literature DB >> 24722128

Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS).

Evangelia Tantalaki1, Christina Piperi2, Sarantis Livadas1, Anastasios Kollias1, Christos Adamopoulos2, Aikaterini Koulouri1, Charikleia Christakou1, Evanthia Diamanti-Kandarakis1.   

Abstract

OBJECTIVE: To investigate the impact of dietary intervention on Advanced Glycation End products (AGEs) intake on the hormonal and metabolic profile in women with polycystic ovary syndrome (PCOS).
METHODS: After baseline evaluation, 23 women with PCOS [mean ± SD, age: 23.4 ± 5.7 years; body mass index (BMI): 26 ± 5.7 kg/m2] underwent the following consecutive 2-month dietary regimens: a hypocaloric diet with ad-libitum AGEs content (Hypo), an isocaloric diet with high AGEs (HA) and an isocaloric diet with low AGEs (LA). Metabolic, hormonal and oxidative stress status was assessed and AGEs levels were determined in all subjects after the completion of each dietary intervention.
RESULTS: Serum levels of AGEs, testosterone, oxidative stress, insulin and HOMA-IR index were significantly increased on the HA compared to the Hypo diet and subsequently decreased on the LA diet (compared to HA) (p<0.05 for all parameters). BMI remained unaltered throughout the HA and LA periods compared to the Hypo period. Serum AGEs were strongly correlated with insulin, as well as with HOMA, during the LA dietary period (r=0.53, p=0.02 and r=0.51, p=0.03, respectively). For the same period, dietary AGEs were correlated with insulin levels (rho=0.49, p=0.04).
CONCLUSIONS: Modifications of dietary AGEs intake are associated with parallel changes in serum AGEs, metabolic, hormonal and oxidative stress biomarkers in women with PCOS. These novel findings support recommendations for a low AGEs dietary content along with lifestyle changes in women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722128     DOI: 10.1007/BF03401321

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  21 in total

1.  How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Authors:  P Moghetti; E Carmina; V De Leo; A Lanzone; F Orio; R Pasquali; V Toscano
Journal:  J Endocrinol Invest       Date:  2015-04-03       Impact factor: 4.256

Review 2.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

3.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

4.  Advanced glycation end-products and insulin signaling in granulosa cells.

Authors:  Evanthia Diamanti-Kandarakis; Antonios Chatzigeorgiou; Efstathia Papageorgiou; Dimitrios Koundouras; Michael Koutsilieris
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-07

Review 5.  A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).

Authors:  Sana Siddiqui; Somaiya Mateen; Rizwan Ahmad; Shagufta Moin
Journal:  J Assist Reprod Genet       Date:  2022-10-03       Impact factor: 3.357

Review 6.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

Review 7.  Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?

Authors:  Deepika Garg; Zaher Merhi
Journal:  Nutrients       Date:  2015-12-04       Impact factor: 5.717

Review 8.  Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS.

Authors:  Deepika Garg; Zaher Merhi
Journal:  Reprod Biol Endocrinol       Date:  2016-10-21       Impact factor: 5.211

Review 9.  Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management.

Authors:  Sotiria Palimeri; Eleni Palioura; Evanthia Diamanti-Kandarakis
Journal:  Diabetes Metab Syndr Obes       Date:  2015-09-01       Impact factor: 3.168

Review 10.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.